CPR Market Surveillance: How EU Authorities Monitor and Enforce Construction Product Compliance

Market surveillance is the backbone of the EU’s construction products regulatory framework. Without robust enforcement, even the most carefully designed Declaration of Performance means nothing. Under the Construction Products Regulation 2024/3110 (CPR), market surveillance authorities (MSAs) across EU Member States hold significant powers to inspect, test, and where necessary remove non-compliant products from the European market. For manufacturers, importers, and distributors, understanding how market surveillance works — who conducts it, what triggers an investigation, and what consequences follow — is not merely academic. It is a prerequisite for operating responsibly and sustainably in the EU construction sector. This article provides a comprehensive, authoritative guide to CPR market surveillance: its legal basis, operational mechanics, enforcement hierarchy, and practical implications for all economic operators.

1. The Legal Framework Underpinning CPR Market Surveillance

1.1 Regulation 2024/3110 and Its Surveillance Provisions

The recast Construction Products Regulation 2024/3110, which replaced and significantly expanded upon Regulation (EU) No 305/2011 (CPR 2011), dedicates substantial provisions to market surveillance. The new CPR reinforces the obligations of economic operators, strengthens the mandate of national market surveillance authorities, and aligns construction product enforcement with the broader EU market surveillance architecture established under Regulation (EU) 2019/1020 on market surveillance and compliance of products.

Regulation (EU) 2019/1020, often referred to as the Market Surveillance Regulation (MSR), provides the horizontal framework that governs how MSAs across all product sectors — including construction products — must operate. It sets out the powers MSAs must have, the obligations of economic operators, and the mechanisms for cross-border cooperation. CPR 2024/3110 builds on this framework with sector-specific requirements reflecting the unique nature of construction products: their long service lives, their integration into immovable works, and the fundamental safety implications they carry for buildings and infrastructure.

1.2 The Role of Harmonised Standards and European Assessment Documents

Harmonised standards (hENs) published in the Official Journal of the EU define the methods by which essential characteristics of construction products are assessed and declared. When a product bears CE marking under a harmonised standard, it is presumed to comply with the essential requirements relating to that standard. Market surveillance authorities use these same harmonised standards as the technical benchmark for their conformity assessments. Where no hEN exists, European Assessment Documents (EADs) issued through EOTA (European Organisation for Technical Assessment) and the resulting European Technical Assessments (ETAs) serve the equivalent function.

Failure to correctly apply the relevant harmonised standard — for example, omitting mandatory performance declarations, using incorrect assessment and verification of constancy of performance (AVCP) systems, or making CE marking errors — constitutes a formal non-compliance that MSAs are empowered to act upon.

2. Who Conducts Market Surveillance? Authorities, Roles, and Coordination

2.1 National Market Surveillance Authorities

Each EU Member State designates one or more competent national authorities responsible for CPR market surveillance. In practice, this designation varies considerably by country. In Germany, market surveillance is conducted at the Länder level through individual state building authorities. In France, the Direction Générale de la Concurrence, de la Consommation et de la Répression des Fraudes (DGCCRF) plays a central role alongside technical bodies. In Poland, the Office of Technical Inspection (Urząd Dozoru Technicznego) and construction supervisory inspectorates share responsibilities.

Despite this national variation, all MSAs must fulfil the minimum powers prescribed under Regulation (EU) 2019/1020. These include the power to require economic operators to provide technical documentation, the power to conduct on-site inspections without prior notice, the authority to commission product testing, and the ability to impose corrective measures including product withdrawal and market bans.

2.2 The ADCO Construction Group

Coordination between national MSAs at the EU level is facilitated through the Administrative Cooperation Group for Construction Products (ADCO Construction). Operating under the auspices of the European Commission, ADCO brings together representatives of national MSAs to share intelligence on non-compliant products, align inspection priorities, and develop common approaches to enforcement. ADCO publishes joint market surveillance campaigns and coordinates sweeps targeting specific product categories — such as fire-resistant doors, anchors, or facade insulation panels — that have historically shown elevated non-compliance rates.

2.3 Customs Authorities and Border Controls

For products entering the EU from third countries, customs authorities serve as the first line of surveillance. Regulation (EU) 2019/1020 formalises the cooperation between customs and MSAs, requiring customs to suspend the release of products where there are reasonable grounds for suspecting non-compliance. This is particularly relevant for construction products imported from China, Turkey, and other major third-country manufacturing hubs, where the supply chain may be less transparent and notified body involvement more difficult to verify.

3. What Market Surveillance Authorities Actually Check

3.1 CE Marking and Declaration of Performance

The CE marking on a construction product is not merely a label — it is a legal statement that the product has been assessed in accordance with the applicable harmonised standard, that a Declaration of Performance (DoP) has been drawn up, and that the product meets all applicable formal requirements. MSAs routinely verify whether the CE marking is correctly affixed, whether the DoP is accessible (since CPR 2024/3110 mandates digital availability), and whether the content of the DoP — including the stated AVCP system, the notified body involvement, and the declared performance levels — corresponds to the actual product in the market.

A frequent finding in market surveillance inspections is CE marking affixed without a corresponding DoP, or a DoP referencing a harmonised standard that has not yet come into mandatory effect or has already been superseded. Both constitute non-compliances that can trigger enforcement action.

3.2 Technical Documentation and Traceability

Under CPR 2024/3110, manufacturers must maintain technical documentation for a minimum of ten years after the last product has been placed on the market. This documentation must be sufficient to allow MSAs to verify that the product conforms to the declared performance. For importers and distributors, obligations vary, but all economic operators must be able to identify the manufacturer and, where applicable, the notified body involved in third-party assessment.

MSAs have the authority to request full technical documentation at any point within the retention period. Non-production of documentation upon legitimate request is itself a compliance failure, independent of whether the underlying product is conformant.

3.3 Product Testing and Sampling

Where documentation review is insufficient or where there are reasonable grounds for suspicion, MSAs can order product sampling and independent laboratory testing. Testing is conducted against the same harmonised standards used for the original declaration. Where test results reveal that declared performance levels are not actually achieved — for example, a fire door declared to EI2 60 minutes that fails at 35 minutes — the MSA can order immediate corrective action and initiate formal non-compliance proceedings.

The costs of testing are typically borne by the economic operator where non-compliance is confirmed. This creates a significant financial incentive to maintain accurate and substantiated performance declarations from the outset.

3.4 Labelling, Instructions, and Safety Information

CPR 2024/3110 and its delegated acts introduce enhanced requirements for product labelling, including digital product passports for certain product categories. MSAs verify that labelling meets the formal requirements of the applicable harmonised standard and any additional national requirements, that instructions for use are available in the official language(s) of the Member State where the product is placed on the market, and that safety information is adequate and accurate.

4. Triggers for Market Surveillance Investigations

4.1 Complaint-Driven Investigations

A significant proportion of CPR market surveillance investigations are triggered by complaints — from contractors, installers, building control bodies, competitors, or end users. A complaint might allege that a structural steel section does not achieve its declared yield strength, that a waterproofing membrane fails prematurely in service, or that a product claiming compliance with a particular harmonised standard has never actually been tested by a notified body. MSAs are obliged under Regulation (EU) 2019/1020 to follow up on substantiated complaints, though they retain discretion in prioritising their investigative resources.

4.2 Planned Sector Sweeps and Joint Campaigns

ADCO Construction coordinates periodic joint market surveillance campaigns targeting high-risk product categories. Past campaigns have focused on facade fire performance, anchor systems, and thermal insulation products. During these campaigns, MSAs across multiple Member States simultaneously draw samples and conduct testing according to a common protocol, enabling direct cross-border comparison of compliance rates and facilitating coordinated enforcement against manufacturers supplying non-compliant products across multiple markets simultaneously.

4.3 RAPEX and ICSMS Notifications

The Rapid Alert System (RAPEX) — now formally designated as the Safety Gate under EU product safety law — and the Information and Communication System for Market Surveillance (ICSMS) both serve as triggers for CPR-related investigations. When one Member State identifies a non-compliant construction product posing a serious risk and enters it into ICSMS or notifies RAPEX, other Member States are expected to verify whether the same product is present in their market and take corresponding action. This mutual recognition of enforcement findings is a core feature of EU market surveillance architecture.

4.4 Post-Market Incidents and Structural Failures

Serious structural failures, fire incidents in buildings, or other safety events involving construction products almost invariably trigger market surveillance investigations. Where a product’s declared performance is implicated in an incident — for example, a fire-rated partition that did not perform as declared, contributing to fire spread — MSAs can initiate retrospective investigations covering the product’s entire market history. These investigations can lead not only to enforcement action but also to precautionary measures such as withdrawal of all products from the same production batch.

5. Enforcement Powers and Corrective Measures

5.1 The Enforcement Hierarchy

CPR market surveillance enforcement follows a graduated hierarchy. At the first level, MSAs issue formal notifications requiring economic operators to bring products into conformity within a specified period. This might involve correcting a DoP, replacing incorrect CE marking, or submitting additional technical documentation. Where the economic operator complies within the required timeframe, no further action may be necessary.

At the second level, where voluntary compliance is not forthcoming or where the non-compliance poses an immediate risk, MSAs can issue binding orders requiring product withdrawal from the market, prohibition of further placing on the market, or mandatory recall from end users. These measures are proportionate to the severity and nature of the non-compliance.

At the most severe level, MSAs can impose administrative sanctions including substantial financial penalties. Under CPR 2024/3110 and implementing national legislation, penalties for serious CPR non-compliance can reach significant amounts — in some Member States, penalties of several hundred thousand euros are provided for, particularly where non-compliance involves fraudulent performance declarations or deliberate misuse of notified body certification.

5.2 Safeguard Clause and EU-Wide Measures

Where a Member State takes restrictive measures against a construction product and notifies the Commission through ICSMS, the Commission evaluates the measure and, if it finds it to be justified, can adopt EU-wide implementing acts extending the restriction to all Member States. This safeguard clause mechanism ensures that a single market surveillance finding in one country can, where warranted, result in pan-EU enforcement — a particularly powerful instrument when dealing with large-scale non-compliance affecting the entire internal market.

5.3 Notified Body Involvement and NANDO Implications

Where an MSA finds that a notified body has issued certificates or conducted assessments that do not meet the requirements of CPR 2024/3110, the MSA can refer the matter to the national accreditation body and to the Commission. This can result in suspension or withdrawal of the notified body’s designation, with all certificates issued by that body coming under scrutiny. Notified body designations are published in the NANDO (New Approach Notified and Designated Organisations) database, and withdrawal from NANDO has immediate and severe commercial consequences for the body and for manufacturers relying on its certificates.

6. Obligations of Economic Operators Under Market Surveillance

6.1 Manufacturer Obligations

Manufacturers bear the primary responsibility for CPR compliance. Beyond the initial obligations to draw up a DoP and affix CE marking, manufacturers must cooperate fully with MSAs during investigations, providing all requested documentation within the specified timeframe, making products available for sampling, and facilitating inspector access to production facilities where requested. Obstruction of an MSA investigation is a serious aggravating factor in enforcement proceedings.

Manufacturers must also maintain a systematic approach to post-market monitoring. Where a manufacturer becomes aware of information suggesting that a product they have placed on the market does not conform to its declared performance, they are obliged to take immediate corrective action and, where appropriate, notify the relevant MSA. This self-reporting obligation, strengthened under CPR 2024/3110, represents a fundamental shift from purely reactive to proactive compliance management.

6.2 Importer and Distributor Obligations

Importers who place products from third countries on the EU market bear obligations that closely mirror those of manufacturers. Before placing a product on the market, importers must verify that the manufacturer has drawn up the required DoP, that CE marking is correctly affixed, and that the required documentation is available. Where an importer has reasonable grounds to believe a product is not compliant, they must not place it on the market.

Distributors, while carrying lighter obligations, must verify that products bear CE marking and are accompanied by the required documentation before making them available. They must cooperate with MSAs on request and must immediately notify the manufacturer and relevant authorities where they have reason to believe a product poses a risk.

6.3 Authorised Representatives

For manufacturers established outside the EU, CPR 2024/3110 reinforces the role of the Authorised Representative (AR) — an entity established within the EU and mandated by the manufacturer to act on their behalf. The AR is the primary point of contact for MSAs where the manufacturer cannot be reached directly. The AR must hold a copy of the DoP and technical documentation and must be able to produce them upon MSA request. Failure to maintain an effective AR arrangement is a common non-compliance finding for third-country manufacturers.

7. Practical Compliance Strategies for Economic Operators

7.1 Proactive Documentation Management

The single most effective defence against adverse market surveillance outcomes is meticulous documentation management. Manufacturers should maintain a complete, version-controlled technical file for every product, including all test reports, notified body certificates, factory production control records, and DoP versions. This documentation should be reviewed and updated whenever the product, its manufacturing process, or the applicable harmonised standard changes. Digital document management systems that provide clear audit trails are strongly recommended, both for operational efficiency and for demonstrating systematic compliance during inspections.

7.2 Internal Audit and Mock Inspections

Regular internal CPR compliance audits — conducted either by qualified in-house personnel or by external experts — allow manufacturers to identify and correct non-compliances before MSAs do. Mock inspections that simulate an MSA visit, reviewing documentation against regulatory requirements, walking through the factory production control system, and verifying CE marking and DoP accuracy, are an established best practice among leading EU construction product manufacturers. The cost of a compliance audit is invariably far lower than the cost of an enforcement action.

7.3 Engagement with Notified Bodies

Notified bodies are not merely certification service providers — they are technical partners in the compliance process. Regular engagement with your notified body beyond mandatory surveillance visits, including participation in relevant harmonised standard development processes and early consultation on new product launches, reduces the risk of certification surprises and keeps your compliance programme aligned with evolving technical requirements. Where a harmonised standard is being revised, proactive engagement with the notified body ensures a smooth transition to the new requirements.

8. Recent Trends and Future Developments in CPR Market Surveillance

8.1 Digitalisation and the Digital Product Passport

CPR 2024/3110 introduces provisions for digital product passports for certain construction product categories, enabling MSAs to access product compliance information electronically and in real time. The digital DoP — already mandated under the new CPR — is a first step in this direction. As the digital product passport framework matures, MSAs will increasingly rely on digital tools for remote surveillance, cross-referencing declared performance data against laboratory test databases and notified body certificate registries automatically.

8.2 Sustainability and Environmental Performance

One of the most significant expansions in CPR 2024/3110 is the addition of Basic Requirement 8 (sustainable use of natural resources) alongside strengthened provisions for environmental performance declarations. MSAs are beginning to extend their surveillance activities to cover environmental performance declarations, particularly relating to carbon content, recycled material claims, and end-of-life scenarios. Economic operators making environmental performance claims in connection with CE marking must ensure these are substantiated with the same rigour as structural or fire performance claims.

8.3 Increased Cross-Border Cooperation and AI-Assisted Surveillance

The European Commission’s broader market surveillance reform agenda envisions increased use of artificial intelligence and data analytics to identify risk patterns and prioritise surveillance resources. For CPR, this means MSAs will increasingly cross-reference product data from ICSMS, customs declarations, and notified body certificate databases to identify anomalies suggesting non-compliance — for example, a product appearing in multiple Member States under the same CE marking but with materially different test results, or a product bearing a certificate from a notified body that has since had its designation suspended.

Summary

CPR market surveillance is a sophisticated, multi-layered enforcement system operating at national and EU level to ensure that construction products placed on the European market genuinely perform as declared. Underpinned by Regulation 2024/3110 and the horizontal Market Surveillance Regulation (EU) 2019/1020, the system empowers national MSAs with significant investigative and enforcement powers, coordinated through ADCO Construction and supported by RAPEX/ICSMS notification mechanisms.

For economic operators — manufacturers, importers, distributors, and authorised representatives — the implications are clear. Compliance cannot be treated as a one-time certification exercise. It is a continuous obligation encompassing documentation maintenance, post-market monitoring, proactive MSA cooperation, and genuine alignment between declared performance and actual product performance. As CPR 2024/3110 is progressively implemented, including its provisions on digital product passports, environmental performance, and enhanced economic operator obligations, the intensity and sophistication of market surveillance will only increase. Organisations that invest in robust compliance infrastructure now will be best positioned to navigate this evolving regulatory landscape with confidence.

Frequently Asked Questions (FAQ)

Q1: What is the difference between market surveillance and conformity assessment under the CPR?

Conformity assessment is the process by which a manufacturer — often with the involvement of a notified body — establishes that a construction product meets the requirements of the applicable harmonised standard before placing it on the market. It is a pre-market activity. Market surveillance, by contrast, is a post-market activity conducted by national authorities to verify that products already placed on the EU market actually conform to their declared performance and meet all applicable legal requirements. Both processes are essential: conformity assessment prevents non-compliant products from entering the market, while market surveillance catches those that nonetheless do.

Q2: Can a market surveillance authority inspect a construction site directly, or only distribution channels?

MSAs have broad powers under Regulation (EU) 2019/1020 and can, in principle, conduct checks at any point in the supply chain where a construction product is present, including construction sites, distribution warehouses, retail outlets, and manufacturing facilities. In practice, construction sites are subject to additional regulatory regimes (building permits, construction supervision), and MSA inspections at sites often occur in coordination with building control authorities. Where a product has already been incorporated into a building, remedial action becomes significantly more complex, which is why MSAs tend to prioritise intervention at the manufacturing, import, and distribution stages before products reach installation.

Q3: What should a manufacturer do immediately upon receiving notification of a CPR market surveillance investigation?

Upon receiving notification of a CPR market surveillance investigation, a manufacturer should immediately take several steps. First, preserve all relevant technical documentation relating to the product under investigation — do not modify, delete, or overwrite any records. Second, identify and engage legal and regulatory compliance advisors with CPR expertise. Third, conduct an internal review of the DoP, CE marking, technical file, and factory production control records to understand your compliance position before responding to the MSA. Fourth, respond to the MSA within the stated deadline — failure to respond in time is treated as non-cooperation and constitutes an aggravating factor. Fifth, if you identify a genuine non-compliance during your internal review, consider whether proactive disclosure and voluntary corrective action is appropriate, as this often results in more proportionate enforcement outcomes than a defensive posture that is subsequently overturned by MSA findings.

Q4: How does the RAPEX (Safety Gate) notification process work for construction products?

When a national MSA identifies a construction product that poses a serious risk to health, safety, or the environment — and takes restrictive measures (withdrawal, recall, prohibition) against it — the MSA is required to notify the European Commission through the Safety Gate (formerly RAPEX) system. The Commission reviews the notification and distributes it to all Member States via ICSMS. Each Member State’s MSA is then expected to investigate whether the same product is present in their market and to take equivalent measures where appropriate. The notifying MSA must also indicate whether the risk is considered serious enough to require EU-wide action, in which case the Commission may initiate a formal evaluation that could lead to binding EU-wide measures. Notifications are published publicly on the Safety Gate portal, making them visible to all market participants and creating significant reputational consequences for the manufacturer concerned.

Q5: Are distributors at risk of market surveillance enforcement, or is it primarily manufacturers who face action?

While manufacturers bear primary CPR responsibility, distributors are not immune from enforcement action. Under CPR 2024/3110 and Regulation (EU) 2019/1020, distributors have specific obligations to verify CE marking and documentation before making products available, to cooperate with MSA investigations, and to take immediate action — including notifying authorities — where they have reason to believe a product is non-compliant or poses a risk. A distributor that continues to sell a product after being notified of its non-compliance, or that fails to cooperate with an MSA investigation, can face enforcement action independently of the manufacturer. In practice, enforcement action against distributors is most common where they have played an active role in the non-compliance — for example, by sourcing products from non-EU manufacturers while failing to exercise proper due diligence as an importer, or by making misleading performance claims that go beyond the manufacturer’s DoP.

Q6: How long does a typical CPR market surveillance investigation take, and what are the stages?

The duration of a CPR market surveillance investigation varies considerably depending on its complexity, the number of products involved, and whether laboratory testing is required. A straightforward documentation check — verifying CE marking, DoP availability, and basic formal requirements — can be resolved within weeks. An investigation involving product sampling, independent laboratory testing against harmonised standards, and potential cross-border coordination through ADCO or ICSMS may take six to eighteen months or longer. The typical stages are: initial notification and document request; document review; product sampling and testing where required; preliminary findings communicated to the economic operator; opportunity for the operator to respond and provide additional evidence; final findings and determination; corrective measures or enforcement action where warranted; and monitoring of compliance with any ordered measures. Throughout this process, economic operators retain the right to be heard and to challenge findings through administrative and judicial review mechanisms provided under national law.

Q7: Does obtaining a European Technical Assessment (ETA) provide any advantage or protection in market surveillance?

A European Technical Assessment (ETA) issued by a designated Technical Assessment Body (TAB) provides a comprehensive, independently verified technical basis for the CE marking and DoP of construction products for which no harmonised standard exists. In a market surveillance context, a valid ETA — particularly one issued recently and covering the current product configuration — provides strong documentary evidence that the product’s essential characteristics have been rigorously assessed by a competent independent body. This does not render a product immune from market surveillance scrutiny, as MSAs retain the power to verify conformity between the actual product and the ETA scope, and to test whether declared performance levels are actually achieved. However, a well-maintained ETA with current factory production control certificates from a notified body significantly reduces the risk of adverse surveillance outcomes and demonstrates the systematic compliance commitment that MSAs expect from responsible economic operators.